128 related articles for article (PubMed ID: 12142149)
1. Another NICE mess.
Lancet Oncol; 2002 Jul; 3(7):385. PubMed ID: 12142149
[No Abstract] [Full Text] [Related]
2. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
Punt CJ
Ann Oncol; 2005 Jun; 16(6):845-6. PubMed ID: 15890668
[No Abstract] [Full Text] [Related]
3. Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecan.
Pazdur R
J Gastroenterol; 2000; 35 Suppl 12():131. PubMed ID: 10779234
[No Abstract] [Full Text] [Related]
4. Current perspectives in the treatment of metastatic colorectal cancer.
Köhne CH; Folprecht G
Ann Oncol; 2004; 15 Suppl 4():iv43-53. PubMed ID: 15477334
[No Abstract] [Full Text] [Related]
5. [Chemotherapy of colorectal carcinoma].
Lutz MP; Adler G
Internist (Berl); 2001 Dec; 42(12):1567-8, 1571-6, 1578-82. PubMed ID: 11793596
[No Abstract] [Full Text] [Related]
6. (Neo-)adjuvant treatments in colorectal cancer.
Arnold D; Schmoll HJ
Ann Oncol; 2005; 16 Suppl 2():ii133-40. PubMed ID: 15958444
[No Abstract] [Full Text] [Related]
7. Current and ongoing trials with irinotecan in the United States.
Fuchs CS
Semin Oncol; 2003 Aug; 30(4 Suppl 12):9-17. PubMed ID: 14508722
[No Abstract] [Full Text] [Related]
8. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
[No Abstract] [Full Text] [Related]
9. Indications and effect on survival of standard chemotherapy in advanced colorectal cancer.
Kallinowski B
Recent Results Cancer Res; 2005; 165():245-9. PubMed ID: 15865040
[TBL] [Abstract][Full Text] [Related]
10. Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line.
Grothey A; Sargent D
J Clin Oncol; 2005 Dec; 23(36):9441-2. PubMed ID: 16361649
[No Abstract] [Full Text] [Related]
11. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
[No Abstract] [Full Text] [Related]
12. The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
Poston GJ
Eur J Surg Oncol; 2005 May; 31(4):325-30. PubMed ID: 15837036
[TBL] [Abstract][Full Text] [Related]
13. [Colon carcinoma. Consensus of therapeutic strategies].
Graeven U; Schmiegel W
Internist (Berl); 2000 Sep; 41(9):876-85. PubMed ID: 11006875
[No Abstract] [Full Text] [Related]
14. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
[No Abstract] [Full Text] [Related]
15. Randomized trial comparing the addition of oxaliplatin or irinotecan to high-dose leucovorin and 5-Fluorouracil intravenous bolus every two weeks in metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group 0103.
Comella P
Clin Colorectal Cancer; 2003 Nov; 3(3):186-9. PubMed ID: 14706179
[No Abstract] [Full Text] [Related]
16. [New oxaliplatin-based regimens].
Zaniboni A
Tumori; 2000; 86(3 Suppl):S25. PubMed ID: 10969612
[No Abstract] [Full Text] [Related]
17. The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients.
Scartozzi M; Sobrero A; Gasparini G; Berardi R; Catalano V; Graziano F; Barni S; Zaniboni A; Beretta GD; Labianca R; Cascinu S;
Oncology; 2005; 68(2-3):212-6. PubMed ID: 16015036
[TBL] [Abstract][Full Text] [Related]
18. N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer.
Goldberg RM
Clin Colorectal Cancer; 2002 Aug; 2(2):81. PubMed ID: 12453321
[No Abstract] [Full Text] [Related]
19. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.
Price TJ; Townsend AR; Khattak A
Ann Oncol; 2010 Oct; 21(10):2121; author reply 2121-2. PubMed ID: 20860991
[No Abstract] [Full Text] [Related]
20. [Adjuvant chemotherapy for colorectal carcinoma].
Schallhorn A
Internist (Berl); 2000 Apr; 41(4):387-8. PubMed ID: 10798189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
